Log In
Print
BCIQ
Print
Print this Print this
 

Staccato loxapine (AZ-104)

  Manage Alerts
Collapse Summary General Information
Company Alexza Pharmaceuticals Inc.
DescriptionLow-dose loxapine delivered via Staccato system inhaler
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT2) receptor antagonist
Latest Stage of DevelopmentPhase II
IndicationMigraine
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today